Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Other financing activities (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Other financing activities for 3 consecutive years, with $6000.0 as the latest value for Q1 2025.

  • Quarterly Other financing activities changed N/A to $6000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $6000.0 through Mar 2025, down 90.32% year-over-year, with the annual reading at $2.7 million for FY2023, 875.27% up from the prior year.
  • Other financing activities for Q1 2025 was $6000.0 at Spruce Biosciences, down from $62000.0 in the prior quarter.
  • The five-year high for Other financing activities was $2.7 million in Q1 2023, with the low at $2000.0 in Q4 2022.
  • Average Other financing activities over 3 years is $555800.0, with a median of $50000.0 recorded in 2022.